Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium for Paraspinal Muscle Relaxation in Spine Surgery
NCT03318718Completed
- Sponsor
- University Hospital Balgrist
- Start
- Feb 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of rocuronium, sponsored by University Hospital Balgrist. Primary endpoints: Neuromuscular blocking agent blockade assessment, Motor Evoked Potentials and 1 more. Started Feb 2016; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on NCT03318718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318718.